Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer
Sung Won Lim, Myung-Ju Ahn
Korean J Intern Med. 2019;34(1):50-59.   Published online 2018 Sep 3     DOI: https://doi.org/10.3904/kjim.2018.179
Citations to this article as recorded by Crossref logo
Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation
Nahyeon Kang, Su Yeon Choi, Bit Na Kim, Chang Dong Yeo, Chan Kwon Park, Young Kyoon Kim, Tae-Jung Kim, Seong-Beom Lee, Sug Hyung Lee, Jong Y. Park, Mi Sun Park, Hyeon Woo Yim, Seung Joon Kim
BMC Cancer.2019;[Epub]     CrossRef
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy
Jun Ying, Danfei Zhou, Tongjie Gu, Jianda Huang, Haijian Liu
BMC Cancer.2019;[Epub]     CrossRef